Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

We tend to view ourselves and the complex cells that build us as a distinct branch of the tree of life from the compact, seemingly featureless cells of bacteria and archaea. But we’ve found that our ...

Cancer cells need large amounts of energy to survive and multiply. To produce that energy, they rely on structures inside the cell called mitochondria, often described as the cell's "powerhouse." ...

The really big surprises were no longer part of it when Julian Nagelsmann announced his squad for the 2026 World Cup last Thursday. Quite a few eager journalists had already “leaked” several days ...

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. In recent years, incidence rates in the overall population have decreased, despite an increase among younger people [1 ...

A research consortium has established a new framework to identify and catalog senescent cells—cells that stop dividing but remain active in the body. Because senescent cells accumulate with age and ...

A recent study by Ruibao Li and Jennah Dharamshi published in Nature may help us understand the beginnings of animal evolution billions of years ago. These findings are the result of a collaboration ...

Researchers have captured the first atomic structures of human SMUG1, an enzyme that helps cells repair damaged DNA. The findings provide new insight into how cells recognize and remove harmful DNA ...

Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...

The U.S. Army is preparing to carry out four executions if President Donald Trump gives the order to do so, according to an internal planning document reviewed by ABC News. The plan, if carried out, ...

With a drug candidate in hand sooner than expected, NewLimit plans to push into a phase 1 fatty liver disease trial next year. (iStock / Getty Images Plus) Anti-aging startup NewLimit is back with a ...